Search Results - "tyrosine kinase"

Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors by Richard Honeywell, Christien Fatmawati, Marita Buddha, Sarina Hitzerd, Ietje Kathman, Godefridus Peters

Connect to this object online.

Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases by Ruixin Gu, Wei Zhang, Dandan Xu

Connect to this object online.

Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib by Dheyaa Tohma Madlool, Israa Al-Ani, Tha'er Ata, Wael Abu Dayyih

Connect to this object online.

Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer by Ying-Hsia Shih, Cheng-Liang Peng, Ping-Fang Chiang, Ming-Jium Shieh

Connect to this object online.

Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil by Andreia D. MENEZES, Nelson A. FRAIJI

Connect to this object online.

Pharmacological inhibition of protein tyrosine kinases axl and fyn reduces TNF-α-induced endothelial inflammatory activation in vitro by Sophie F. Ellermann, Sophie F. Ellermann, Sophie F. Ellermann, Rianne M. Jongman, Rianne M. Jongman, Matthijs Luxen, Matthijs Luxen, Timara Kuiper, Josee Plantinga, Jill Moser, Jill Moser, Thomas W. L. Scheeren, Gregor Theilmeier, Gregor Theilmeier, Grietje Molema, Matijs Van Meurs, Matijs Van Meurs

Connect to this object online.

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management by Hang Zhang, Kenneth K. W. To

Connect to this object online.

Second-generation Tyrosine Kinase Inhibitors Nilotinib- and Dasatinib-induced Keratosis Pilaris: A Case Report and Review of the Literature by Hussein M. Alshamrani, Marwan Alsaedi, Hosam Alaradati

Connect to this object online.

Transformation of adenocarcinoma into small cell lung cancer as one of the mechanisms of acquired resistance to anti-EGFR tyrosine kinase inhibitors by O. O. Kovalov, O. P. Tolok, K. O. Kovalov

Connect to this object online.

New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular target to clinical trials by Kai eQu, Zichao eHuang, Ting eLin, Sinan eLiu, Hulin eChang, Zhaoyong eYan, Hongxin eZhang, Chang eLiu

Connect to this object online.

Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants by Sibel Ucpinar, Patrick F. Smith, Li Long, Fujun Li, Hui Yan, Jyoti Wadhwa, Katherine A. Chu, Jin Shu, Philip Nunn, Mengyao Li

Connect to this object online.

Safety profile of vascular endothelial growth factor receptor tyrosine-kinase inhibitors in pediatrics: a pharmacovigilance disproportionality analysis by Yifei Xue, Shuo Feng, Guangyao Li, Chao Zhang

Connect to this object online.

Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors by Krisztina Futosi, Krisztina Futosi, Boglárka Bajza, Dorottya Deli, András Erdélyi, Simon Tusnády, Attila Mócsai, Attila Mócsai

Connect to this object online.

Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia by Raquel Vinhas, Alexandra R. Fernandes, Pedro V. Baptista

Connect to this object online.

Gastric Cancer An Update

Subjects: “…gist, chemotherapy, quality of life, tyrosine kinase inhibitors, art…”
DOAB: download the publication
DOAB: description of the publication

Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs by Fereshteh Shiri, Somayeh Pirhadi, Jahan B. Ghasemi

Connect to this object online.

The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation by Dennis Y. Kim, Joanna Yu, Ryan K. Mui, Rieko Niibori, Hamza Bin Taufique, Rukhsana Aslam, John W. Semple, Sabine P. Cordes

Connect to this object online.

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors by Dominique A. Garrison, Zahra Talebi, Eric D. Eisenmann, Alex Sparreboom, Sharyn D. Baker

Connect to this object online.

Computational quest, synthesis and anticancer profiling of 3-methyl quinoxaline-2-one-based active hits against the tyrosine kinase by Priyadarsini Raj, Abiseik Samuel, Anitha Kothandapani

Connect to this object online.

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients by Ji Su Lee, Jimin Woo, Tae Min Kim, Namkyu Kim, Bhumsuk Keam, Seong Jin Jo

Connect to this object online.